Interview with Andreas Windischbauer, CEO, Herba Chemosan
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
Address: Haidestraße 4, 1110 Vienna,Austria
Tel: +43 1 401 04-0
Web: http://www.herba-chemosan.at/de/home/index.jsp
The Herba Apotheker-AG, with a market share of 43% not only the leading pharmaceutical wholesaler and service provider in Austria, but also has the highest level of dynamics. Seven companies form over Austria’s densest logistics network for the provision of drugs and health products. They guarantee fast operations and simplified work processes and thus for better quality control and higher deliverability. But the stock range comprises more than 42,000 articles. Several times a day we serve over 1,000 pharmacies, doctors and hospitals. In addition, the Herba Group offers its customers to support a comprehensive portfolio of services in the areas of marketing and organization. Nearly 1,000 employees contribute to the success of the company. Since 2000, the Herba Apotheker-AG is part of the German Celesio AG based in Stuttgart, whose majority shareholder is the Franz HANIEL jr. GmbH , headquartered in Duisburg.
Herba is the industry leader in pharmaceutical distribution. Almost every second drug that is delivered in an Austrian chemist on Tara, comes from one of our seven distribution centers. In addition to the largest assortment of drugs and health products, we offer our customers special ranges and other services in the areas of raw materials, kits, pharmacy IT and through our subsidiary Sanova on its own assortment line.
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
Dr. Wolfgang Schnitzel, general manager of Shire Austria, and Karl-Heinz Hofbauer, site lead Vienna and managing director for the Technical Operations business, discuss the huge impact of Shire’s 32 billion…
Maria Seriakov, CEO and founder of M bioserviceS, a young Austrian company dealing globally that specialises in logistics, regulatory affairs and quality control of biologics, discusses the challenges of navigating…
Prof. Ruth Ladenstein, executive director of the Medicines for Children Research Organisation (OKIDS) in Austria, explains OKIDS’ drive to ensure drugs are paediatric specific by conducting child-specific clinical trials. Furthermore,…
Philipp Lindinger, managing director of Austromed, the Austrian association for medical devices and in-vitro diagnostics, discusses the organization’s purpose, the impact of European regulation on medical devices on the sector,…
Martin Prinz, CTO of Croma-Pharma, a family-owned Austrian aesthetic dermatology company, discusses the evolution of the company over the years and their specialist, ever-expanding portfolio. Additionally, he documents the role…
Mario Huber, general manager of PharmaMar Austria, a multinational and an innovative oncology-based Spanish company, discusses the growth of the company in Austria and the reasons behind the success of…
Michael Stampfer, managing director of the Vienna Science and Technology Fund (WWTF), the only private, non-profit organization in Vienna dedicated to funding scientific research, discusses the challenges scientific research faces…
Michaela Latzelsberger, country manager of Coloplast Austria, a Danish medical device company focused on ostomy, continence and wound care, discusses the challenges of launching innovative medical devices on the Austrian…
Urs Weber, general secretary of the Swiss Chamber of Commerce in Austria, discusses the role of the chamber as a networking facilitator between Austrian and Swiss companies as well as…
Heidrun Katholnigg, executive director of global clinical development Europe for Celerion, a global CRO that specialises in phase I, II and III clinical trials, discusses the acquisition of Assign Group…
Ulrich Schlick, deputy managing director of the German Chamber of Commerce in Austria, discusses the Chamber’s role in facilitating business opportunities for German companies in Austria and vice versa. He…
Bernd Grabner, board member of Jacoby GM pharma, a leading Austrian wholesaler, provides an in-depth look into the historical merger of family owned Jacoby, GM pharma and Kӧgl Pharma as…
See our Cookie Privacy Policy Here